COMP <GO>
HSIC vs MOH // EV/EBITDA & P/E VALUATION
Henry Schein Inc. (NASDAQ) VS. Molina Healthcare Inc (NYSE) • 15-METRIC TALLY: HSIC 6
— MOH 7
▲ EV/EBITDA & P/E VALUATION LEADER: HSIC
LAST: $86.62 (+2.05%) • MKT CAP: $9.46B
valuation
9.5x
LAST: $208.45 (+1.79%) • MKT CAP: $10.69B
valuation
11.4x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (HSIC VS. MOH)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | HSIC | MOH | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 31.10% | 13.10% | +18.00 | HSIC | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 11.20% | 17.20% | -6.00 | MOH | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 9.5x | 11.4x | -1.90 | HSIC | /valuation <GO> |
| Free Cash Flow Yield | 1.23% | -6.12% | +7.35 | HSIC | /fcf-yield <GO> |
| Operating Margin | 5.00% | 1.70% | +3.30 | HSIC | /operating-margins <GO> |
| Net Profit Margin | 3.20% | 1.00% | +2.20 | HSIC | /net-margins <GO> |
| Revenue Growth (YoY) | 4.00% | 11.70% | -7.70 | MOH | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.81 | 4.34 | -1.53 | MOH | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 4/9 | +3.00 | HSIC | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 47.5 | 52.0 | -4.50 | MOH | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.89 | 0.94 | -0.05 | MOH | /macro-sensitivity <GO> |
| Forward P/E Multiple | 21.4x | 20.5x | +0.90 | MOH | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $9.46B | $10.69B | -$1.23B | MOH | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | HSIC REV | MOH REV | HSIC GROSS % | MOH GROSS % | HSIC FCF | MOH FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $13.18B | $45.43B | 31.1% | 13.1% | $118.7M | -$636.0M |
| FY 2024 | $12.67B | $40.65B | 31.7% | 15.3% | $277.7M | $544.0M |
| FY 2023 | $12.34B | $34.07B | — | — | -$55.3M | $128.8M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
HSIC // BETA 0.89
MOH // BETA 0.94